Insider record · § COB,
CEO, 10% Bentsur Ron insider buys
Every disclosed SEC Form 4 open-market purchase by CEO, 10% Bentsur Ron (COB, · NVCT), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.
Disclosed buys
1
Total bought
$250K
Avg Δ7d
+2.0%
Win rate · 7d
100%
Avg Δ30d
—
Last filing
2026-07-01
Buy history
| Filed | Ticker | Company | Value | Price @ | Δ1d | Δ7d | Δ30d |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | NVCT | Nuvectis Pharma, Inc. | $250K | $18.39 | +6.4% | +2.0% | — |